Research

Kristina Krohn, MD
Known as “the Minnesota Project,” this early leadership in global medicine is one of many inspiring reasons why Kristina Krohn, MD, joined the faculty at the U of M Medical School in 2017.

Sophia Yohe, MD
A desire to plant roots closer to home drew Sophia Yohe, MD, to the University of Minnesota Medical School.

Rumi Faizer, MD
Rumi Faizer, MD, brought a passion to discover why that happens to the University of Minnesota Medical School in 2012. Today, he is an associate professor in the Department of Surgery and an aortic surgeon.

Surbhi Shah, MD, assistant professor in the Department of Medicine’s Division of Hematology, Oncology and Transplantation, and Brad Holschuh, PhD, assistant professor in the College of Design, plan to create a new compression garment for patients suffering from chronic venous insufficiency (CVI).

John J Marini, MD, and Luciano Gattinoni, MD, have co-authored “Management of COVID-19 Respiratory Distress,” which was published in JAMA Insights, April 24, 2020.

A study led by the University of Minnesota, including Glenn Simmons Jr., PhD, in the Department of Biomedical Sciences in Duluth, looks at how using social networking could provide better access to health education for African American men.

A new antibody test developed by the laboratory of Marc Jenkins, PhD, is now in clinical use with the help of Amy Karger, MD, PhD, and the Advanced Research and Diagnostic Laboratory at the University of Minnesota.

Professor Mustafa al’Absi, PhD, and his team of researchers with the Stress and Resilience Laboratories seek to understand the effects of stress on addictive behaviors.

University of Minnesota Medical School researchers have begun enrolling patients in newly launched clinical trials involving a blood pressure medication, losartan, as a potential treatment for those recently diagnosed with COVID-19.

Bruce Walcheck, PhD, describes how membership in the Medical School’s Stem Cell Institute led to today’s first-ever, FDA-approved clinical trial using genetically-engineered, induced pluripotent stem cells (iPSC) to treat various cancers.

Pages